This was a 20-week, open-label, uncontrolled clinical investigation of the long-acting
calcium antagonist amlodipine in 33 male or female patients with essential hypertension …

Background: The effects of the antihypertensive therapy with amlodipine (5-10 mg/day) on
left ventricular mass and diastolic function were examined in 30 mild to moderate essential …

To determine the dose-response efficacy of once-daily administration of placebo or a new
long-acting calcium channel blocker amlodipine in patients with mild to moderate …

As part of the Amlodipine Cardiovascular Community Trial (ACCT), which was a large
multicenter study designed to assess the effects of the calcium channel blocker amlodipine …

In an 18-month randomised single-blind trial, M-mode and Doppler echocardiography were
used to compare the effects of enalapril (10 to 20 mg/day) and amlodipine (5 to 10 mg/day) …

Using digitized M-mode echocardiograms and 24-hour noninvasive ambulatory blood
pressure monitoring, we evaluated the effects of 1 year treatment with amlodipine on left …

Amlodipine, a new long-acting dihydropyridine calcium antagonist, was compared with
placebo and atenolol in 125 patients with mild to moderate systemic hypertension [supine …

The antihypertensive efficacy and safety of amlodipine was evaluated in an open,
multicenter general practice study. Hypertensive patients with sitting diastolic blood pressure …

Amlodipine is a new long-acting calcium antagonist that has a long half-life and appears to
be suitable for once-daily administration. A double-blind, randomized, parallel, placebo …

In 30 patients with mild to moderate essential hypertension and high-normal left ventricular
(LV) mass, the effects of treatment for 6 months with amlodipine (5 to 10 mg every morning) …